Sean Grant Sells 99,828 Shares of Vera Therapeutics, Inc. (NASDAQ:VERA) Stock

Vera Therapeutics, Inc. (NASDAQ:VERA – Get Free Report) CFO Sean Grant sold 99,828 shares of the firm’s stock in a transaction dated Wednesday, April 3rd. The stock was sold at an average price of $39.61, for a total transaction of $3,954,187.08. Following the completion of the transaction, the chief financial officer now directly owns 66,337 […]

Related Keywords

Wellington ,New Zealand General ,New Zealand ,Switzerland ,Swiss ,Raymond James ,Citigroup Inc ,Vera Therapeutics Inc ,Swiss National Bank ,Securities Exchange Commission ,Barclays Plc ,Cantor Fitzgerald ,Rafferty Asset Management ,Nasdaq ,Wellington Management Group ,Vera Therapeutics ,Get Free Report ,Exchange Commission ,National Bank ,Asset Management ,Vera Therapeutics Daily ,Nasdaq Vera ,Vera ,Medical ,Insider Trading ,Nsider Trades ,Stocks ,